XML 26 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Class A common stock
Total Stockholders' Equity
Class A common stock
Common Stock
Class A common stock
Additional Paid-In Capital
Class A common stock
Noncontrolling Interests
Class A common stock
Unvested restricted stock
Total Stockholders' Equity
Unvested restricted stock
Additional Paid-In Capital
Unvested restricted stock
Noncontrolling Interests
Unvested restricted stock
Class B common stock
Common Stock
Class B common stock
Noncontrolling Interests
Class B common stock
Total Stockholders' Equity
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Noncontrolling Interests
Total
Beginning balance at Dec. 31, 2021   $ 942               $ 162     $ 592,096 $ 950,464 $ (359,472) $ 103,078 $ 695,174
Beginning balance (in shares) at Dec. 31, 2021   94,172,920               16,221,101              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
ESPP shares issued                         52 52   1 53
ESPP shares issued (in shares)   6,973                              
Equity-based compensation                         13,395 13,395   2,175 15,570
Issuance of restricted shares   $ 29                     2,592 2,563   (2,592)  
Issuance of restricted shares (in shares)   2,923,073                              
Cashless exercise of options   $ 1                     584 583   24 608
Cashless exercise of options (in shares)   70,000                              
Issuance of shares for acquisitions   $ 152                     135,690 135,538   5,269 140,959
Issuance of shares for acquisition (in shares)   15,247,832                              
Repurchase of common stock   $ (28)                     (20,374) (20,346)   (445) (20,819)
Repurchase of common stock ( in shares)   (2,822,547)                              
Restricted shares forfeited   $ (2)                     (186) (184)   186  
Restricted shares forfeited (in shares)   (208,723)                              
Distributions to noncontrolling interests                         (1,943) (1,943)     (1,943)
Contributions from noncontrolling interests                               4,797 4,797
Purchase of noncontrolling interest                         1,077 1,077   (389) 688
NCI income tax adjustment                         53 53   (53)  
Dividend and distribution declared $ (5,143)   $ (5,143) $ (66) $ (5,209) $ (194) $ (194) $ 1 $ (193)   $ (811) $ (811)          
Net income                         48,278   48,278 6,576 54,854
Ending balance at Dec. 31, 2022   $ 1,094               $ 162     765,977 1,075,915 (311,194) 117,751 883,728
Ending balance (in shares) at Dec. 31, 2022   109,389,528               16,221,101              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Equity-based compensation                         15,040 15,040   2,329 17,369
Issuance of restricted shares   $ 16                     1,519 1,503   (1,520) (1)
Issuance of restricted shares (in shares)   1,689,004                              
Repurchase of common stock   $ (86)                     (61,707) (61,621)   (63) (61,770)
Repurchase of common stock ( in shares)   (8,617,986)                              
Issuance of shares for acquisition                         (401) (401)   (9) (410)
Issuance of shares for merger (in shares)   (48,688)                              
Restricted shares forfeited   $ (2)                     (214) (212)   214  
Restricted shares forfeited (in shares)   (238,995)                              
Distributions to noncontrolling interests                               (1,581) (1,581)
Contributions from noncontrolling interests                               1,153 1,153
Dividend and distribution declared (21,274)   (21,274)   (21,274) (855) (855)   (855)   (3,406) (3,406)          
Net income                         74,403   74,403 4,816 79,219
Ending balance at Dec. 31, 2023   $ 1,022               $ 162     772,488 1,008,095 (236,791) 119,684 892,172
Ending balance (in shares) at Dec. 31, 2023   102,172,863               16,221,101              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Equity-based compensation                         22,765 22,765   3,593 26,358
Issuance of restricted shares   $ 15                     1,573 1,558   (1,573)  
Issuance of restricted shares (in shares)   1,528,167                              
Cash exercise of options                         50 50     50
Cash exercise of options (in shares)   5,575                              
Cashless exercise of options   $ 4                     3,752 3,748     3,752
Cashless exercise of options (in shares)   426,693                              
Repurchase of common stock   $ (12)                     (11,542) (11,530)   (262) (11,804)
Repurchase of common stock ( in shares)   (1,242,678)                              
Restricted shares forfeited   $ (1)                     (132) (131)   132  
Restricted shares forfeited (in shares)   (124,805)                              
Performance shares vested   $ 3                     311 308   (311)  
Performance shares vested (in shares)   303,917                              
Deferred taxes on partnership basis from equity movement                         (751) (751)     (751)
Dividend and distribution declared $ (24,968)   $ (24,968)   $ (24,968) $ (670) $ (670)   $ (670)   $ (4,055) $ (4,055)          
Net income                         30,644   30,644 4,806 35,450
Ending balance at Dec. 31, 2024   $ 1,031               $ 162     $ 793,520 $ 998,474 $ (206,147) $ 122,014 $ 915,534
Ending balance (in shares) at Dec. 31, 2024   103,069,732               16,221,101